Diagnosis of parathyroid incidentaloma detected on thyroid ultrasonography: the role of fine-needle aspiration cytology and washout parathyroid hormone measurements

Boeun Lee; Sae Rom Chung; Young Jun Choi; Tae-Yon Sung; Dong Eun Song; Tae Yong Kim; Jeong Hyun Lee; Jung Hwan Baek

doi:10.14366/usg.22105

Journal List > Ultrasonography > v.42(1) > 1516091313

Go to TopGo to Top Go to BottomGo to Bottom

TOOLS

Lee, Chung, Choi, Sung, Song, Kim, Lee, and Baek: Diagnosis of parathyroid incidentaloma detected on thyroid ultrasonography: the role of fine-needle aspiration cytology and washout parathyroid hormone measurements

Original Article

Ultrasonography 2023;42(1):129-135.

Published online: 28 August 2022

DOI: https://doi.org/10.14366/usg.22105

Diagnosis of parathyroid incidentaloma detected on thyroid ultrasonography: the role of fine-needle aspiration cytology and washout parathyroid hormone measurements

Boeun Lee¹

, Sae Rom Chung²

, Young Jun Choi²

, Tae-Yon Sung³

, Dong Eun Song⁴

, Tae Yong Kim⁵

, Jeong Hyun Lee²

, Jung Hwan Baek²

¹Department of Radiology, Ewha Womans University Seoul Hospital, Ewha Womans University College of Medicine, Seoul, Korea

²Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea

³Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea

⁴Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea

⁵Department of Endocrinology and Metabolism, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea

Correspondence to: Sae Rom Chung, MD, PhD, Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Korea Tel. +82-2-3010-0753 Fax. +82-2-476-0090 E-mail: jserom@naver.com

Received 22 June 2022 Revised 12 August 2022 Accepted 28 August 2022

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Purpose

The aim of this study was to assess the diagnostic role of fine-needle aspiration cytology (FNAC) and analyze factors associated with false-negative FNAC results in patients with parathyroid incidentaloma who were referred for ultrasonography (US)-guided fine-needle aspiration (FNA) of thyroid nodules.

Methods

In this study, 121 patients with suspected parathyroid lesions were enrolled. The patients underwent US-guided FNAC with measurements of washout parathyroid hormone (PTH) between January 2015 and May 2020. The diagnostic performance of FNAC for the diagnosis of parathyroid lesions was assessed using surgical results and elevated washout PTH as a reference standard. The clinical and radiologic features associated with false-negative results on FNAC for the diagnosis of parathyroid lesions were evaluated.

Results

Among the 121 nodules assessed, 38 were parathyroid lesions (31.4%), and 83 were non-parathyroid lesions (68.6%). The diagnostic performance of FNAC for parathyroid incidentaloma showed a sensitivity of 31.6% (12/38), specificity of 100% (83/83), positive predictive values of 100% (12/12), negative predictive values of 76.1% (83/109), and accuracy of 78.5% (95/121). The FNAC results of non-parathyroid lesions included thyroid nodules, lymph nodes, neurogenic tumors, and fat tissue. True-positive results on FNAC were significantly associated with performing FNA twice (58.3% vs. 23.1%, P=0.043).

Conclusion

Considering the low sensitivity of FNAC, measuring washout PTH in addition to FNAC may help accurately diagnose parathyroid incidentaloma on thyroid US. Further, the falsenegative rate for FNAC can be reduced by obtaining two or more FNA samples.

Keywords: Parathyroid incidentaloma, Neck ultrasonography, Fine-needle aspiration cytology, Parathyroid hormone

Key point

The cytologic results of fine-needle aspiration (FNA) have limited diagnostic ability to distinguish between parathyroid and thyroid lesions. Using washout parathyroid hormone in addition to FNA cytology is necessary for the accurate diagnosis of parathyroid incidentaloma on thyroid ultrasonography. The false-negative rate of FNA cytology can be reduced by obtaining two or more FNA samples.

Introduction

The widespread use of high-resolution neck ultrasonography (US) for thyroid lesions has increased the frequency of incidentally detected parathyroid lesions [1,2]. An incidentally discovered parathyroid lesion on neck imaging for a non-parathyroid disease is called a parathyroid incidentaloma [1,3]. Parathyroid lesions are suspected when extrathyroid soft tissue is seen at the posterior and inferior portions of the thyroid gland, separated from the thyroid parenchyma. However, in such cases, a parathyroid lesion should be differentiated from exophytic thyroid nodule, lymph node (LN), normal fat, and other soft tissue mass. It is often difficult to differentiate parathyroid lesions from non-parathyroid lesions owing to overlapping imaging findings [4,5]. Therefore, fine-needle aspiration (FNA) is needed to distinguish parathyroid lesions from non-parathyroid lesions. Several studies have reported the diagnostic performance of FNA cytology (FNAC) and washout parathyroid hormone (PTH) measurements for the diagnosis of parathyroid adenoma [1,3,6-13]. However, limited studies have evaluated the diagnostic performance of FNAC for parathyroid incidentaloma [3]. Therefore, this study aimed to evaluate the diagnostic role of FNAC and analyze the factors associated with false-negative results of FNAC in patients with parathyroid incidentaloma who were referred for US-guided FNA of thyroid nodules.

Materials and Methods

Compliance with Ethical Standards

This retrospective study was approved by the review board of the authors’ affiliated institution (Asan Medical Center 2021-1861), and written informed consent was obtained from all patients before performing FNA.

Patient Selection

Consecutive patients who underwent US-guided FNAC with measurements of washout PTH at the authors’ institution between January 2015 and May 2020 were included. Patients were included if they underwent US-guided FNA with measurement of washout PTH for an incidentally detected suspected parathyroid lesion. Patients were excluded if (1) they underwent US-guided FNA with measurement of washout PTH for the evaluation of hypercalcemia or hyperparathyroidism, (2) had a known history of parathyroid lesions, or (3) if the evaluated lesion was identified as a pure cyst. Finally, 121 suspected parathyroid lesions from 121 patients were included in this study.

US-Guided FNA and FNA-PTH

Ultrasound examination of the thyroid was performed using an iU22 or HDI-5000 unit (Philips Healthcare, Bothell, WA, USA) or an EUB-7500 unit (Hitachi Medical Systems, Tokyo, Japan) with a 5-14-MHz linear high-frequency probe. All US examinations and US-guided FNA procedures were performed by radiologists under the supervision of staff radiologists having more than 14 years of experience in thyroid imaging. Before performing FNA, thyroid and neck US examinations were performed. When a well-defined, oval, hypoechoic or isoechoic nodule was noted as being separate from the thyroid parenchyma, parathyroid incidentalomas were suspected [1]. When parathyroid incidentalomas were suspected, PTH measurements from the washout fluid were performed in addition to FNAC.

FNA was performed under US guidance with a free-hand technique using a 23-gauge needle connected to a 10-mL syringe. All FNA specimens were prepared from liquid-based cytology. The specimens were prepared using a ThinPrep 2000 processor (Hologic Co., Marlborough, MA, USA). The same needle and syringe were rinsed with 1 mL of normal saline, and PTH was measured in the washout fluid. If there was more than 1 mL of aspirate, PTH was measured in this fluid without adding saline. The cytology findings were interpreted by cytopathologists specializing in thyroid and parathyroid cytology. PTH assays were performed using commercial polyclonal antibody immunoradiometric assay kits.

Image Analysis

US images were reviewed retrospectively and independently by two radiologists with 11 and 10 years of experience, respectively, in thyroid US. Neither reviewer had any knowledge of the patients’ clinical histories, previous imaging results, or cytopathology results. Any discrepancy between the two reviewers was resolved by consensus. US findings of the nodules were evaluated for the following features: the nodule’s size, depth, and location; the presence of normal thyroid tissue along the course of needle insertion; echogenicity (hyperechoic, isoechoic, or hypoechoic); the presence of cystic change; and intranodular vascularity.

Biochemical and Scintigraphy Study

In patients with parathyroid lesion, biochemical studies including serum PTH and total calcium levels and scintigraphy were performed.

Reference Standard

The final diagnosis of a parathyroid lesion was made upon: (1) confirmation of a surgical specimen or (2) a washout PTH measurement higher than 65 pg/mL-the upper normal limit of PTH in a blood test. Lesions deemed free of parathyroid lesions by the same criteria were finally diagnosed as non-parathyroid lesions.

Statistical Analysis

Continuous variables are expressed as mean±standard deviation, and categorical variables are shown as percentages. To evaluate differences in patients’ demographic data between lesions of parathyroid and non-parathyroid origin, the Student t-test was used for continuous variables, while the chi-square test or Fisher exact test was used for categorical variables.

The cytologic results were classified as parathyroid or non-parathyroid based on their origin. The diagnostic performance of FNAC for parathyroid lesions was assessed using sensitivity, specificity, the positive predictive value (PPV), the negative predictive value (NPV), and diagnostic accuracy.

To evaluate differences in clinicoradiologic features between true-positive and false-negative results on the FNAC of parathyroid lesions, the chi-square test or Fisher exact test was used for categorical variables, while the Student t-test was used for continuous variables. The statistical analysis was performed using SPSS version 23 (IBM Corp., Armonk, NY, USA).

Results

Study Population

A total of 121 patients underwent FNAC and washout PTH measurements for 121 suspected parathyroid lesions. Of these lesions, 38 were parathyroid lesions (31.4%), and 83 were nonparathyroid lesions (68.6%). The diagnosis of parathyroid lesions was based on surgical confirmation in 21 patients and elevated washout PTH in 17 patients (Fig. 1). The pathologic results of the surgical specimens were parathyroid adenoma (n=20) and atypical parathyroid adenoma (n=1). All parathyroid lesions showed elevated washout PTH, except for one case, which showed a washout PTH level of 8.9 pg/mL; the FNAC result was nondiagnostic, and the lesion was confirmed as a parathyroid adenoma after surgery. A retrospective image review indicated that this discrepancy was attributable to mistargeting of the nodule. Serum PTH was measured in 34 patients with parathyroid lesions. The serum PTH level was elevated in 26 patients (67.9-671 pg/mL) and normal in eight patients (39.1-63.6 pg/mL). The serum ionized calcium level was elevated in 22 patients (10.2 to 12.3 mg/dL) and non-elevated in 14 patients. Among 83 patients with non-parathyroid lesions, 71 (85.5%) had specific cytologic results, as follows: thyroid lesion (n=59), LN (n=11), and neurogenic tumor (n=1). The remaining 12 patients (14.5%) showed nondiagnostic results on FNAC, and the lesions were identified as comprising fat tissue, LN, and thyroid tissue on follow-up. There were no complications after FNA.

Scintigraphy was performed in 26 of 121 patients, including 20 patients with parathyroid lesions and six patients with non-parathyroid lesions. Of the six patients with non-parathyroid lesions, two patients had false-positive results on scintigraphy, and all 20 patients with parathyroid lesions revealed sestamibi uptake. Therefore, the sensitivity and specificity of scintigraphy were 100% and 66.7%, respectively. The lesions showing false-positive scintigraphy results in two patients were confirmed as thyroid nodules.

Table 1 shows the differences in the clinical and radiologic features between parathyroid and non-parathyroid lesions. Parathyroid lesions more commonly showed hypoechogenicity than non-parathyroid lesions (94.7% vs. 60.2%, P<0.001) and intranodular vascularity (92.1% vs. 59.0%, P<0.001). There was no difference in the mean age of the patients, size of the lesion, or the proportion of cystic change between the two groups.

Diagnostic Performance of FNAC

Table 2 shows the diagnostic performance of FNAC for the diagnosis of parathyroid lesions. The sensitivity, specificity, PPV, NPV, and diagnostic accuracy of FNAC for the diagnosis of parathyroid lesions were 31.6% (12/38), 100% (83/83), 100% (12/12), 76.1% (83/109), and 78.5% (95/121), respectively. There were 26 false-negative results on FNAC (68.4 %). The most common results were thyroid lesion (atypia of undetermined significance [n=8] and benign follicular nodule [n=5]), followed by nondiagnostic results (n=10), and LN (n=3).

Factors Associated with False-Negative Results on FNAC

Table 3 shows a comparison of the clinical and radiologic features of cases with false-negative and true-positive results on FNAC for the diagnosis of parathyroid lesions. The number of false-negative and true-positive results in FNA cases differed significantly. The proportion of cases where FNA was performed twice was significantly higher in the true-positive cases than in the false-negative cases (58.3% vs. 23.1%, P=0.043). Other clinicoradiologic features, including size, distance from the nodule, location, overlying thyroid gland, cystic change, vascularity, echogenicity, and proficiency of the operator, showed no differences between the two groups.

Discussion

In the present study, 68.6% of patients who underwent FNA for parathyroid incidentaloma were diagnosed with non-parathyroid lesions. The diagnostic performance of FNAC for parathyroid incidentaloma showed a low sensitivity of 31.6%. A meaningful correlation was found between performing FNA twice and true-positive results of FNAC for parathyroid lesions. Therefore, when FNA is performed for parathyroid incidentaloma, as the sensitivity of FNAC for diagnosing parathyroid lesion is low, washout PTH measurements should be added. In addition, performing FNAC twice can improve the accuracy of FNAC for the diagnosis of parathyroid lesions, as well as many diseases that can mimic parathyroid lesions.

Parathyroid incidentaloma on thyroid US was more common than expected, as the prevalence of suspected parathyroid lesions was reported to be 0.45%-0.6% [1,3]. Parathyroid lesions can be suspected when extra thyroid soft tissue is seen at the posterior portion of the thyroid gland, separate from the thyroid parenchyma. However, in this situation, parathyroid lesions should be differentiated from exophytic thyroid nodules, LNs, normal fat, and other soft tissue masses. In this study, the most common final diagnosis of suspected parathyroid lesions on thyroid US was exophytic thyroid nodule (n=67, 55.4%), followed by parathyroid adenoma (n=38, 31.4%), LN (n=13, 10.7%), fat (n=2, 1.7%), and neurogenic tumor (n=1, 0.8%). In this study, hypoechogenicity of the nodule and intranodular vascularity were more often seen in parathyroid lesions than in non-parathyroid lesions (P<0.001). These results are consistent with previous studies [14-20]. The intranodular vascularity of parathyroid adenomas is related to the polar feeding vessel arising from the inferior thyroidal artery branches [17], and hypoechogenicity results from the high cellularity of parathyroid adenomas (with chief cell proliferation) and their low content of fatty tissue [18-20].

Because US examinations are performed to localize the lesions when evaluating patients with hyperparathyroidism, FNA is not essential. Furthermore, FNA for parathyroid adenomas has potential risks, including tumor seeding, massive hemorrhage, parathyromatosis, recurrence, or histological alterations following FNA [21-27]. However, for parathyroid incidentalomas, FNA is often needed to differentiate various diseases that can overlap with parathyroid lesions [28]. The diagnostic ability of FNAC to distinguish parathyroid lesions from thyroid lesions is known to be limited [1,3,7-13]. Previous studies have reported that the diagnostic sensitivity of FNAC in the diagnosis of parathyroid lesions was 29%-41.7% [3,7,8]. However, several other studies have reported a relatively high sensitivity of FNAC for the diagnosis of parathyroid lesions (86%–86.7%), and the available clinical information, such as high serum PTH, may explain these differences [29,30]. In the present study, which analyzed the diagnostic performance of FNAC for parathyroid incidentaloma without clinical information, including hyperparathyroidism, the sensitivity was low (31.6%). Of the cytologic results of 26 false-negative cases in FNAC, the most common results were thyroid lesion (n=13, benign or follicular lesion of undetermined significance), followed by nondiagnostic results (n=10) and LN (n=3). Based on FNAC, parathyroid lesions are commonly misdiagnosed as Hürthle cell thyroid neoplasms [31-34] or chronic lymphocytic thyroiditis [14] owing to similarities in cellular morphology, including the presence of follicular and papillary structures, colloid-like material, macrophages and paravacuolar granules [31,35-38]. The presence of oncocytic cells or naked nuclei in parathyroid lesions may be confused with Hürthle cell thyroid neoplasm and lymphocytes, respectively [6,38]. This is the reason why washout PTH measurements are recommended to assess and incidentally detect suspected parathyroid lesions in the neck. For nodules without elevated washout PTH levels, in 84.5% (71/84) of cases, specific cytologic results could be obtained using FNAC. FNAC for the evaluation of parathyroid incidentaloma plays a more important role in the diagnosis when the lesion is not a parathyroid lesion. Therefore, it is important to measure washout PTH combined with FNAC when performing FNA for parathyroid incidentaloma to properly manage these patients.

Sestamibi scintigraphy is widely used to localize parathyroid adenomas, especially in preoperative evaluations of patients with primary hyperparathyroidism. One meta-analysis reported that sestamibi scintigraphy had a higher sensitivity than US (88% vs. 78% for single adenomas) [39]. In addition, combined US and scintigraphy had higher sensitivity, specificity, and accuracy [40-42]. In the present study, the sensitivity of scintigraphy was 100%. Considering the high sensitivity of scintigraphy, it can be used as a complementary method for reducing the false-negative results of FNA of parathyroid incidentaloma. However, false-positive results on scintigraphs should also be considered. Solitary thyroid adenoma or multinodular goiter, LN, or metastasis may have false-positive findings on scintigraphy [43-47]. In this study, two patients with thyroid nodules showed false-positive results on scintigraphy.

The clinical and radiologic factors associated with false-negative results of FNAC were analyzed. US features, such as size, echogenicity, cystic change, vascularity, the location and depth of nodules, and the operator’s proficiency, did not reach statistical significance, whereas the number of FNAs was significantly associated with false-negative results on FNAC. The cases of elevated washout PTH despite nondiagnostic cytology may indicate that it is difficult to make an accurate diagnosis due to an insufficient number of cells [48]. Therefore, performing FNA twice or more in parathyroid incidentaloma can improve the accuracy of FNAC for the diagnosis of parathyroid lesions, as well as many diseases that can mimic parathyroid lesions.

This study has several limitations. One of the limitations is its retrospective design. All patients were recruited at a single tertiary referral center, leading to unavoidable selection bias. The final diagnosis of the majority of non-parathyroid lesions (89.2%) was based on FNA results and follow-up imaging studies. This may have caused false-negative results. In addition, the retrospective assessment of static US images has an inherent limitation to the accuracy of US interpretation. Thus, further large-scale, prospective, and multicenter studies are required to validate these results.

In conclusion, considering the low sensitivity of FNAC, the use of washout PTH in addition to FNAC is necessary to accurately diagnose parathyroid incidentaloma on thyroid US. In addition, performing FNAC twice can improve the accuracy of FNAC for the diagnosis of parathyroid lesions, as well as many diseases that can mimic parathyroid lesions.

Notes

Author Contributions

Conceptualization: Chung SR. Data acquisition: Chung SR, Sung TY, Song DE, Kim TY. Data analysis or interpretation: Lee B, Chung SR, Choi YJ, Lee JH, Baek JH. Drafting of the manuscript: Lee B, Chung SR, Sung TY, Song DE. Critical revision of the manuscript: Lee B, Chung SR, Choi YJ, Kim TY, Lee JH, Baek JH. Approval of the final version of the manuscript: all authors.

No potential conflict of interest relevant to this article was reported.

References

1. Frasoldati A, Pesenti M, Toschi E, Azzarito C, Zini M, Valcavi R. Detection and diagnosis of parathyroid incidentalomas during thyroid sonography. J Clin Ultrasound. 1999; 27:492–498.

2. Pesenti M, Frasoldati A, Azzarito C, Valcavi R. Parathyroid incidentaloma discovered during thyroid ultrasound imaging. J Endocrinol Invest. 1999; 22:796–799.

3. Kwak JY, Kim EK, Moon HJ, Kim MJ, Ahn SS, Son EJ, et al. Parathyroid incidentalomas detected on routine ultrasounddirected fine-needle aspiration biopsy in patients referred for thyroid nodules and the role of parathyroid hormone analysis in the samples. Thyroid. 2009; 19:743–748.

4. Han MG, Yoon JH, Kim SJ, Kim HK, Cho JS, Kang HC. Comparison of ultrasonography and 99mTc-sestamibi scan for preoperative localization of parathyroid adenoma. Korean J Med. 2015; 89:48–53.

5. Mirhosaini SM, Amani S, Fereidani R. Parathyroid adenoma completely impacted within the thyroid gland: a case report. J Clin Diagn Res. 2016; 10:MD01–02.

6. Abati A, Skarulis MC, Shawker T, Solomon D. Ultrasound-guided fine-needle aspiration of parathyroid lesions: a morphological and immunocytochemical approach. Hum Pathol. 1995; 26:338–343.

7. Abdelghani R, Noureldine S, Abbas A, Moroz K, Kandil E. The diagnostic value of parathyroid hormone washout after fineneedle aspiration of suspicious cervical lesions in patients with hyperparathyroidism. Laryngoscope. 2013; 123:1310–1313.

8. Bancos I, Grant CS, Nadeem S, Stan MN, Reading CC, Sebo TJ, et al. Risks and benefits of parathyroid fine-needle aspiration with parathyroid hormone washout. Endocr Pract. 2012; 18:441–449.

9. Friedman M, Shimaoka K, Lopez CA, Shedd DP. Parathyroid adenoma diagnosed as papillary carcinoma of thyroid on needle aspiration smears. Acta Cytol. 1983; 27:337–340.

10. Glenthoj A, Karstrup S. Parathyroid identification by ultrasonically guided aspiration cytology. Is correct cytological identification possible? APMIS. 1989; 97:497–502.

11. Kini U, Shariff S, Thomas JA. Ultrasonically guided fine needle aspiration of the parathyroid: a report of two cases. Acta Cytol. 1993; 37:747–751.

12. Marcocci C, Mazzeo S, Bruno-Bossio G, Picone A, Vignali E, Ciampi M, et al. Preoperative localization of suspicious parathyroid adenomas by assay of parathyroid hormone in needle aspirates. Eur J Endocrinol. 1998; 139:72–77.

13. Sacks BA, Pallotta JA, Cole A, Hurwitz J. Diagnosis of parathyroid adenomas: efficacy of measuring parathormone levels in needle aspirates of cervical masses. AJR Am J Roentgenol. 1994; 163:1223–1226.

14. Auger M, Charbonneau M, Huttner I. Unsuspected intrathyroidal parathyroid adenoma: mimic of lymphocytic thyroiditis in fineneedle aspiration specimens: a case report. Diagn Cytopathol. 1999; 21:276–279.

15. Lee JH, Anzai Y. Imaging of thyroid and parathyroid glands. Semin Roentgenol. 2013; 48:87–104.

16. Murad V, Barragan C, Rivera H. Ultrasound evaluation of the parathyroid glands. Rev Colomb Radiol. 2018; 29:4861–4866.

17. Sung JY. Parathyroid ultrasonography: the evolving role of the radiologist. Ultrasonography. 2015; 34:268–274.

18. Dufour DR, Wilkerson SY. The normal parathyroid revisited: percentage of stromal fat. Hum Pathol. 1982; 13:717–721.

19. Huppert BJ, Reading CC. Parathyroid sonography: imaging and intervention. J Clin Ultrasound. 2007; 35:144–155.

20. Wieneke JA, Smith A. Parathyroid adenoma. Head Neck Pathol. 2008; 2:305–308.

21. Suzuki A, Hirokawa M, Kanematsu R, Tanaka A, Yamao N, Higuchi M, et al. Fine-needle aspiration of parathyroid adenomas: Indications as a diagnostic approach. Diagn Cytopathol. 2021; 49:70–76.

22. Alwaheeb S, Rambaldini G, Boerner S, Coire C, Fiser J, Asa SL. Worrisome histologic alterations following fine-needle aspiration of the parathyroid. J Clin Pathol. 2006; 59:1094–1096.

23. Norman J, Politz D, Browarsky I. Diagnostic aspiration of parathyroid adenomas causes severe fibrosis complicating surgery and final histologic diagnosis. Thyroid. 2007; 17:1251–1255.

24. Kim J, Horowitz G, Hong M, Orsini M, Asa SL, Higgins K. The dangers of parathyroid biopsy. J Otolaryngol Head Neck Surg. 2017; 46:4.

25. Agarwal G, Dhingra S, Mishra SK, Krishnani N. Implantation of parathyroid carcinoma along fine needle aspiration track. Langenbecks Arch Surg. 2006; 391:623–626.

26. Kendrick ML, Charboneau JW, Curlee KJ, van Heerden JA, Farley DR. Risk of parathyromatosis after fine-needle aspiration. Am Surg. 2001; 67:290–293.

27. Wei CH, Harari A. Parathyroid carcinoma: update and guidelines for management. Curr Treat Options Oncol. 2012; 13:11–23.

28. Obolonczyk L, Karwacka I, Wisniewski P, Sworczak K, Oseka T. The current role of parathyroid fine-needle biopsy (P-FNAB) with iPTH-washout concentration (iPTH-WC) in primary hyperparathyroidism: a single center experience and literature review. Biomedicines. 2022; 10:123.

29. Halbauer M, Crepinko I, Tomc Brzac H, Simonovic I. Fine needle aspiration cytology in the preoperative diagnosis of ultrasonically enlarged parathyroid glands. Acta Cytol. 1991; 35:728–735.

30. Heo I, Park S, Jung CW, Koh JS, Lee SS, Seol H, et al. Fine needle aspiration cytology of parathyroid lesions. Korean J Pathol. 2013; 47:466–471.

31. Paker I, Yilmazer D, Yandakci K, Arikok AT, Alper M. Intrathyroidal oncocytic parathyroid adenoma: a diagnostic pitfall on fine-needle aspiration. Diagn Cytopathol. 2010; 38:833–836.

32. Sriphrapradang C, Sornmayura P, Chanplakorn N, Trachoo O, Sae-Chew P, Aroonroch R. Fine-needle aspiration cytology of parathyroid carcinoma mimic hurthle cell thyroid neoplasm. Case Rep Endocrinol. 2014; 2014:680876.

33. Weymouth MD, Serpell JW, Chambers D. Palpable parathyroid adenomas presenting as clinical solitary thyroid nodules and cytologically as follicular thyroid neoplasms. ANZ J Surg. 2003; 73:36–39.

34. Lieu D. Cytopathologist-performed ultrasound-guided fine-needle aspiration of parathyroid lesions. Diagn Cytopathol. 2010; 38:327–332.

35. Dimashkieh H, Krishnamurthy S. Ultrasound guided fine needle aspiration biopsy of parathyroid gland and lesions. Cytojournal. 2006; 3:6.

36. Lowhagen T, Sprenger E. Cytologic presentation of thyroid tumors in aspiration biopsy smear: a review of 60 cases. Acta Cytol. 1974; 18:192–197.

37. Wong NA, Mihai R, Sheffield EA, Calder CJ, Farndon JR. Imprint cytology of parathyroid tissue in relation to other tissues of the neck and mediastinum. Acta Cytol. 2000; 44:109–113.

38. Bondeson L, Bondeson AG, Nissborg A, Thompson NW. Cytopathological variables in parathyroid lesions: a study based on 1,600 cases of hyperparathyroidism. Diagn Cytopathol. 1997; 16:476–482.

39. Ruda JM, Hollenbeak CS, Stack BC Jr. A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003. Otolaryngol Head Neck Surg. 2005; 132:359–372.

40. Sukan A, Reyhan M, Aydin M, Yapar AF, Sert Y, Canpolat T, et al. Preoperative evaluation of hyperparathyroidism: the role of dualphase parathyroid scintigraphy and ultrasound imaging. Ann Nucl Med. 2008; 22:123–131.

41. De Feo ML, Colagrande S, Biagini C, Tonarelli A, Bisi G, Vaggelli L, et al. Parathyroid glands: combination of (99m)Tc MIBI scintigraphy and US for demonstration of parathyroid glands and nodules. Radiology. 2000; 214:393–402.

42. Lumachi F, Zucchetta P, Marzola MC, Boccagni P, Angelini F, Bui F, et al. Advantages of combined technetium-99m-sestamibi scintigraphy and high-resolution ultrasonography in parathyroid localization: comparative study in 91 patients with primary hyperparathyroidism. Eur J Endocrinol. 2000; 143:755–760.

43. Sandrock D, Merino MJ, Norton JA, Neumann RD. Parathyroid imaging by Tc/Tl scintigraphy. Eur J Nucl Med. 1990; 16:607–613.

44. Taillefer R, Robidoux A, Lambert R, Turpin S, Laperriere J. Technetium-99m-sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement. J Nucl Med. 1995; 36:1758–1765.

45. Yen TC, Tzen KY, Lee CM, Tsai CC. Squamous cell carcinoma of the lung mimicking an ectopic mediastinal parathyroid adenoma demonstrated by Tc-99m sestamibi in a hypercalcemic patient. Clin Nucl Med. 1999; 24:895–896.

46. Yapar Z, Kibar M, Sukan A, Paydas S, Zeren H, Inal M. Coincidental visualization of an atypical bronchial carcinoid on Tc-99m-sestamibi scan in Kallmann's syndrome. Ann Nucl Med. 2002; 16:61–65.

47. Glaser C, Pruckmayer M, Staudenherz A, Rasse M, Lang S, Leitha T. Utility of technetium-99m-sestamibi to assess osseous tumor spread. J Nucl Med. 1996; 37:1526–1528.

48. Cansu GB, Taskiran B, Dizen H, Peker Cengiz B. Parathyroid hormone in washout fluid seems to be superior to cytology for localization of the lesion in MIBI-negative patients with primary hyperparathyroidism. Turk J Med Sci. 2017; 47:1703–1707.

Fig. 1.

Flow chart of patients undergoing ultrasonography -guided fine-needle aspiration cytology (FNAC) and washout parathyroid hormone (PTH) measurements.

Table 1.

Clinicoradiologic characteristics of the patients

	Parathyroid	Non-parathyroid	P-value
Number	38 (31.4)	83 (68.6)
Age (year)	57.74±9.79	56.96±10.96	0.961
Sex (M:F)	9:29	19:64	0.924
Size	1.62±0.79	1.40±0.71
Echogenicity			<0.001
Isoechogenicity	2 (5.3)	33 (39.8)
Hypoechogenicity	36 (94.7)	50 (60.2)
Cystic change	4 (10.5)	18 (21.7)	0.204
Vascularity	35 (92.1)	49 (59.0)	<0.001

Values are presented as number (%) or mean±SD.

Statistical significance was set at P<0.05.

M, male; F, female; SD, standard deviation.

Table 2.

Diagnostic performance of fine-needle aspiration cytology in the diagnosis of parathyroid lesions

	True-positive	False-negative	Sensitivity (%)	Specificity (%)	PPV (%)	NPV (%)	Diagnostic accuracy (%)
Cytology	12	26	31.6 (12/38)	100 (83/83)	100 (12/12)	76.1 (83/109)	78.5 (95/121)

Values in parentheses indicate number.

PPV, positive predictive value; NPV, negative predictive value.

Table 3.

Clinicoradiologic features associated with false-negative results on fine-needle aspiration cytology

	False-negative	True-positive	P-value
Size	1.64±0.77	1.61±0.88	0.856
Distance from the nodule	1.26±0.35	1.36±0.47	0.167
Location			0.743
Upper	9 (34.6)	5 (41.7)
Lower	17 (65.4)	7 (58.3)
Overlying thyroid gland	15 (57.7)	6 (50.0)	0.911
Cystic change	4 (15.4)	0	0.537
Vascularity	25 (96.2)	10 (83.3)	0.099
Echogenicity	25 (96.2)	11 (91.7)	0.324
No. of fine-needle aspirations			0.043
1	20 (76.9)	5 (41.7)
2	6 (23.1)	7 (58.3)
Operator			0.132
Staff	8 (30.8)	7 (58.3)
Non-staff	18 (69.2)	5 (41.7)

Values are presented as mean±standard deviation or number (%).

TOOLS

Similar articles